Swallow, Elyse <br/><br/>
Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012.  [electronic resource] 

 -  Current medical research and opinion  Aug 2014 
 - 1537-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2014.908829  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Databases, Factual<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Guideline Adherence--statistics & numerical data<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Postmenopause<br/>Practice Guidelines as Topic<br/>Practice Patterns, Physicians'--statistics & numerical data<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Retrospective Studies<br/>United States